InCarda Therapeutics
A clinical stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€191m (Public information from Oct 2020)
Palo Alto California (HQ)
Authorizing premium user...